Distinguished in Primary Immunodeficiency (PID)

David M. Lowe

Pond Street, 
London, ENG, GB 
Distinguished in Primary Immunodeficiency (PID)
Pond Street, 
London, ENG, GB 
OverviewLocationsClinical Research

Overview

David Lowe practices in London, United Kingdom. Mr. Lowe is rated as a Distinguished expert by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Common Variable Immune Deficiency, Chronic Granulomatous Disease, Primary Immunodeficiency (PID), Secondary Immunodeficiency (SID), and Bone Marrow Transplant.

His clinical research consists of co-authoring 115 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Primary Immunodeficiency (PID).

Gender
Male

Locations

Pond Street, London, ENG, United Kingdom
Other Locations
Granta Park, Cambridge, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Favipiravir, Lopinavir/Ritonavir or Combination Therapy: a Randomised, Double Blind, 2x2 Factorial Placebo-controlled Trial of Early Antiviral Therapy in COVID-19
Favipiravir, Lopinavir/Ritonavir or Combination Therapy: a Randomised, Double Blind, 2x2 Factorial Placebo-controlled Trial of Early Antiviral Therapy in COVID-19
Enrollment Status: Completed
Publish Date: December 15, 2022
Intervention Type: Drug, Other
Study Drugs: Favipiravir, Lopinavir
Study Phase: Phase 2

115 Total Publications

Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2.
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2.
Journal: The Journal of clinical investigation
Published: September 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lowe's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile